Evidence map›Paper›PMID 32299897›Full record

ArticleBMJ open diabetes research & care2020

Effective diabetes complication management is a step toward a carbon-efficient planet: an economic modeling study.

Ric Fordham, Ketan Dhatariya, Rachel Stancliffe, Adam Lloyd, Mou Chatterjee, Mevin Mathew, Loveleen Taneja, Mike Gains, Ulrik Haagen Panton

Open access · goldAbstract read
In one paragraph

Article in BMJ open diabetes research & care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Ric FordhamThe Health Economics Group, University of East Anglia Norwich Medical School, Norwich, UK.
Ketan DhatariyaElsie Bertram Diabetes Centre, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK ketan.dhatariya@nnuh.nhs.uk.ORCID 0000-0003-3619-9579
Rachel StancliffeCentre for Sustainable Healthcare, Oxford, UK.
Adam LloydHealth Economics and Outcomes Research, IQVIA UK, London, UK.
Mou ChatterjeeHealth Economics and Outcomes Research, IQVIA, Gurgaon, India.
Mevin MathewHealth Economics and Outcomes Research, IQVIA, Gurgaon, India.
Loveleen TanejaHealth Economics and Outcomes Research, IQVIA, Gurgaon, India.
Mike GainsHealth Economics and Outcomes Research, IQVIA UK, London, UK.
Ulrik Haagen PantonEvidence Generation, Novo Nordisk Region Europe Pharmaceuticals A/S, Copenhagen, Denmark.
IQVIA (India) · INIQVIA (United Kingdom) · GBUniversity of East Anglia · GBCentre for Sustainable Healthcare · GBNovo Nordisk (Denmark) · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe management of diabetes-related complications accounts for a large share of total carbon dioxide equivalent (CO

methodsUsing the IQVIA Core Diabetes Model, we estimated the impact of maintaining glycated hemoglobin (HbA

resultsMaintaining HbA

conclusionsWhen comparing people with untreated diabetes, maintaining glycemic control at 7% (53 mmol/mol) on a single agent or improving HbA

Indexed as

Diabetes ComplicationsDiabetes Mellitus, Type 2Glycated HemoglobinHumansPlanetsState MedicineGlycated Hemoglobincost effectivenesseconomic impactenvironmental factorstype 2 diabetes

Identifiers

PMID32299897
PMCPMC7199151
OpenAlexW3016933516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.